Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:09 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 266 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: No intervention/exposures Clear all

Conditions: Retinopathy of Prematurity, Neurodevelopmental Disorders, Macular Edema
Interventions: Swept Source OCT, Magnetic Resonance Imaging, Scavenged blood collection; Device · Other
Lead sponsor: Duke University; Other
Eligibility: 30 Weeks and older
Enrollment: 191 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 4
States / cities: Gainesville, Florida • St Louis, Missouri • Durham, North Carolina + 1 more

Conditions: Deglutition Disorders, Respiratory Aspiration
Interventions: Cold Liquid Barium; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 36 Weeks to 43 Weeks
Enrollment: 4,043 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2024
U.S. locations: 1
States / cities: Mineola, New York

Conditions: Cystic Fibrosis, Pancreatic Insufficiency, Abnormal Glucose Tolerance, Diabetes
Interventions: Dulaglutide 0.75Mg/0.5Ml Inj Pen; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 2
States / cities: Aurora, Colorado • Philadelphia, Pennsylvania

Conditions: HIV-1-infection
Interventions: no intervention; Other
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 100 Years
Enrollment: 565 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Noise Exposure
Interventions: Farmworker Hearing Protection Training; Behavioral
Lead sponsor: San Diego State University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: El Centro, California

Conditions: Frailty, Sarcopenia, Sarcopenia in Elderly, Muscle Strength, Post Operative Complications, Nutrition Assessment, Risk Assessment, Elderly (People Aged 65 or More), Hand Strength
Interventions: Frailty assessment, nutrition assessment, cognition assessment, muscle strength testing; Diagnostic Test
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 65 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Post Operative Patients
Interventions: Food Related Visual Stimuli Exposure; Behavioral
Lead sponsor: Casey Morehouse, DO; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Disorder Related to Bone Marrow Transplantation, Leukemia, Transplantation Infection
Interventions: Fludarabine, Clofarabine, Busulfan, Thymoglobulin, Stem Cell Infusion, Tacrolimus, Methotrexate; Drug · Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 3 Years to 70 Years
Enrollment: 256 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2020
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Allergic Diseases, Asthma
Interventions: Vaginal seeding, Placebo Seeding, Standard care, Post-seeding Care; Drug · Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 2
States / cities: New York, New York

Conditions: Breast Cancer
Interventions: questionnaire, blood draw and urine sample; Behavioral
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Post-traumatic Stress Disorder
Interventions: Transcendental Meditation, Prolonged Exposure, Educational control; Behavioral
Lead sponsor: United States Department of Defense; Federal
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Smoking
Interventions: Informing surgical patients about CO monitoring, a brief intervention recommending preoperative abstinence from smoking; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 169 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Depression, Major Depressive Disorder, Dysthymic Disorder, Depressive Symptoms, Cardiovascular Diseases, Heart Diseases, Coronary Artery Disease, Stroke
Interventions: Beating the Blues (BtB), Problem Solving Treatment in Primary Care (PST-PC), Antidepressant Medications, Usual Care; Behavioral · Drug · Other
Lead sponsor: Indiana University; Other
Eligibility: 50 Years and older
Enrollment: 216 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Acute Kidney Injury, Delirium
Interventions: It is observational trial with no intervention being evaluated; Other
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 25,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Obsessive-Compulsive Disorder
Interventions: Cognitive Behavioral Therapy (CBT), Waitlist; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 6 Years to 18 Years
Enrollment: 119 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2016
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Toxicant Exposure, Firefighter, Occupational Exposure to Chemicals
Interventions: Colesevelam, Placebo; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older · Male only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Myeloma
Interventions: Hyperbaric Oxygen Therapy, No Hyperbaric Oxygen Therapy; Biological · Other
Lead sponsor: Omar Aljitawi; Other
Eligibility: 18 Years to 75 Years
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 3
States / cities: Fairway, Kansas • Lexington, Kentucky • Rochester, New York

Conditions: Depression, Depressive Symptoms, Cardiovascular Disease (CVD), Coronary Artery Disease (CAD), Heart Disease
Interventions: Beating the Blues (BtB), Usual Care; Behavioral · Other
Lead sponsor: Indiana University; Other
Eligibility: 40 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Obsessive-Compulsive Disorder
Interventions: Serotonin reuptake inhibitors management, Cognitive behavioral therapy by a psychologist, Instructional cognitive behavioral therapy by a psychiatrist; Drug · Behavioral
Lead sponsor: Duke University; Other
Eligibility: 7 Years to 17 Years
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 3
States / cities: Durham, North Carolina • Philadelphia, Pennsylvania • Providence, Rhode Island

Conditions: Rheumatoid Arthritis
Interventions: No Interventions; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: Female only
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2019
U.S. locations: 1
States / cities: Princeton, New Jersey

Conditions: Impact of Vaccination
Interventions: Live Attenuated Influenza Vaccine; Biological
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 2 Years to 89 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pre-Exposure Prophylaxis
Interventions: Financial Incentive, Social Media Group; Behavioral
Lead sponsor: George Washington University; Other
Eligibility: 18 Years to 24 Years · Male only
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Nicotine Addiction, Panic Attack
Interventions: d-cycloserine, Pill Placebo, Nicotine replacement therapy, Panic and Smoking Reduction Treatment; Drug · Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 65 Years
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Pancreatic Cancer
Interventions: Endoscopic retrograde cholangiopancreatography - No Intervention have been used other than standard of care; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 100 Years
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2025
U.S. locations: 1
States / cities: Houston, Texas

Search by objective public record fields.

Analyzing Retinal Microanatomy in ROP

Cold Liquids Fed to Preterm Infants: Efficacy and Safety After 10 Minutes of Exposure

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance

Longer-Acting PrEP in Transgender and Gender Diverse Texans

Preventing Noise Exposure in Farmworkers

Frailty and Muscle Strength Tests in Older Adults Undergoing Major Surgery

The Food Network Effect

Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Vaginal Microbiome Exposure and Immune Responses in C-section Infants

Lung Inflammation and Lung Metastases From Breast Cancer

A Randomized Controlled Trial of Meditation Compared to Exposure Therapy and Education Control on PTSD in Veterans

Monitoring of Exhaled Carbon Monoxide to Promote Pre-operative Smoking Cessation

eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients

AKI and Delirium Risk Prediction and Cost Burden Study

Cognitive Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder

Examining a Novel Gastrointestinal Intervention to Negate Environmental Toxicants (ENGINE)

Effects of Hyperbaric Oxygen (HBO) on Blood Count Recovery After Autologous Hematopoietic Stem Cell (HSPC) Transplant for Multiple Myeloma

Beating the Blues for Your Heart

Treatment of Obsessive Compulsive Disorder in Children

Abatacept Pregnancy Exposure Registry

Intranasal LAIV Mucosal Immunity Examination

Effect of Social Media Support and Financial Incentives on PrEP Adherence

Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine

Comparison Of Radiation Exposure To Patients During Endoscopic Retrograde Cholangiopancreatography (ERCP) Performed By Endoscopists Trained In Judicious Use Of Fluoroscopy With Those Without Formal Training